December 13, 2024 Maria Dranishnikova Barchart.com highlights two Wall Street ‘strong buys’ from the Russell 2000
December 12, 2024 Maria Dranishnikova Piper Sandler sees the Russell 2000 outperforming the S&P 500 in 2025
December 11, 2024 Maria Dranishnikova Zacks sees 222% upside in weight-loss market innovator Lexaria Bioscience
December 10, 2024 Maria Dranishnikova Barron’s spotlights six S&P 600 stocks set to keep rallying in 2025
December 6, 2024 Maria Dranishnikova WSJ notes biggest gainers in the small-cap S&P 600 since Trump victory
December 4, 2024 Maria Dranishnikova Zacks SCR reiterates 400% upside call on Nurexone Biologic for risk-tolerant investors
November 29, 2024 Maria Dranishnikova Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute
November 28, 2024 Maria Dranishnikova Stock Trader’s Almanac sees jollier than usual Santa Claus rally for small caps
November 27, 2024 Maria Dranishnikova The Motley Fool spotlights two small caps whose shares are held by Nvidia
November 26, 2024 Maria Dranishnikova InvestorPlace Markets analyst highlights three small caps poised for a comeback in 2025
November 25, 2024 Maria Dranishnikova Royce spotlights three small-cap innovators reshaping their industries
November 20, 2024 Maria Dranishnikova Zacks raises target price for placenta-based drug maker BioStem
November 19, 2024 Maria Dranishnikova Zacks sees 600+% upside in vaping addiction drug maker Achieve Life Sciences
November 18, 2024 Maria Dranishnikova Freedom spotlights small caps poised to rally on Trump second term
November 15, 2024 Maria Dranishnikova Surging TSS seen as alternative to Super Micro as new hot AI stock
November 14, 2024 Maria Dranishnikova Freedom Broker raises Viemed target price amid growing sleep therapy market
November 1, 2024 Maria Dranishnikova Eight small-cap stocks that stand to profit from a rapidly aging U.S.
October 30, 2024 Maria Dranishnikova Motley Fool highlights three small caps that could ‘trounce’ the S&P 500 on five-year horizon
October 28, 2024 Maria Dranishnikova The Motley Fool highlights two small caps with ‘far more’ upside than the Magnificent Seven